Community Health Outreach for Cardiovascular Disease
Cardiomyopathy is a heart disease that affects the heart muscle. In fact, this disease occurs, when the heart muscle is abnormal. There are different types of Cardiomyopathy, which include dilated, hypertrophic, and restrictive Cardiomyopathy. As a rule, the disease affects the elderly population, but younger people are also at risk. Moreover, today, the age group of 24-30 years of age faces the increased risk of the development of the disease because of consistent changes in the lifestyle of people, their nutrition and other factors that increase the risk of the development of Cardiomyopathy. Community Health Outreach for Cardiovascular Disease
In fact, the major risk factors that provoke the development of Cardiomyopathy may be roughly divided into two groups: first, heredity, and second, the lifestyle of patients. The heredity involves the family history since cases of Cardiomyopathy and other cardiovascular diseases in the family history increase the risk of the development of Cardiomyopathy in patients. The lifestyle of patients is also an important factor that can trigger the development of Cardiomyopathy (Lakdawala, et al., 2015). In this regard, obesity, the sedative lifestyle, the consumption of alcohol and drugs, smoking are just a few risk factors to mention. In addition, there are chronic or non-chronic diseases, which may increase the risk of the development of Cardiomyopathym such as diabetes, high blood pressure, thyroid disorders, or other cardiovascular diseases.
In this regard, cultural beliefs may also have a considerable impact on the development of the disease. The specific cultural beliefs of the population at the age of 24 to 30 increase the risk of the development of Cardiomyopathy because this age group consists of young people, who are often in a good physical shape or, at least, have no obvious health problems. However, they often lead the unhealthy lifestyle, which increases the risk of the development of Cardiomyopathy drastically. As a result, the population within the given age group neglects risk factors and becomes vulnerable to the development of the disease (Harvey & Leinwand, 2011). To put it more precisely, young people at the age of 24 to 30 often tend to neglect the negative impact of alcohol and drug consumption on their health. They do not notice obvious negative changes in their health condition. This is why they keep exposing their health at high risk and leading unhealthy lifestyle. Hence, they become vulnerable to the development of Cardiomyopathy. Community Health Outreach for Cardiovascular Disease
At the same time, patients at the age of 24 to 30 should be aware of the fact that their treatment and management of the disease might be affected by these cultural aspects. In fact, the problem is that patients belonging to this age group often overestimate their physical capacity and neglect their health issues. As a result, they may not stick to the treatment defined by their physicians (Klauke, et al., 2010). They may often slip to the wrong diet or simply ignore the diet, which they should follow strictly. They may take alcohol or drugs, regardless of the medication and other methods of treatment applied to them. Hence, the overall effectiveness of the treatment and management of the disease decreases drastically.
In fact, this disease and the management of it affect resources in society consistently because the treatment of Cardiomyopathy is costly. Moreover, young patients, who have Cardiomyopathy cannot perform their physical functions as healthy people of the same age can perform (McCartan, et al., 2012). For example, they cannot perform jobs, which require considerable physical efforts. This is why they cannot perform the same economic activities as others, while costs of their treatment are high. The costly treatment and the loss of a large group lead to the loss of economic opportunities for the entire society. Community Health Outreach for Cardiovascular Disease
References:
Harvey, P. A. and L.A. Leinwand. (2011). “Cellular mechanisms of cardiomyopathy”. The Journal of Cell Biology 194 (3), 355–365.
Klauke, B., et al. (2010). “De novo desmin-mutation N116S is associated with arrhythmogenic right ventricular cardiomyopathy”. Hum. Mol. Genet. 19 (23), 4595–607.
Lakdawala, N.K., et al. (2015). “Chapter 287”. In Kasper, DL; Fauci, AS; Hauser, SL; Longo, DL; Jameson, JL; Loscalzo, J. Harrison’s Principles of Internal Medicine (19th ed.). McGraw-Hill.
McCartan, C., et al. (2012). “Cardiomyopathy Classification: Ongoing Debate in the Genomics Era”. Biochem Res Int. 2012, 796926 Community Health Outreach for Cardiovascular Disease